Edwards Lifesciences Corporation

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 05/07/2024 BST			5-day change	1st Jan Change
92.32 ^USD	+1.36%		-0.05%	+21.08%

07-02	Evercore ISI Adjusts Price Target on Edwards Lifesciences to $91 From $89, Maintains In-line Rating	MT
07-01	Edwards Lifesciences Corporation(NYSE:EW) added to Russell Top 200 Value Index	CI

Edwards Lifesciences Corporation(NYSE:EW) added to Russell 1000 Value-Defensive Index

July 30, 2024

Latest news about Edwards Lifesciences Corporation

Evercore ISI Adjusts Price Target on Edwards Lifesciences to $91 From $89, Maintains In-line Rating	07-02	MT
Edwards Lifesciences Corporation(NYSE:EW) added to Russell Top 200 Value Index	06-30	CI
Edwards Lifesciences Corporation(NYSE:EW) added to Russell 3000E Value Index	06-30	CI
Edwards Lifesciences Corporation(NYSE:EW) added to Russell 3000 Value Index	06-30	CI
Edwards Lifesciences Corporation(NYSE:EW) added to Russell 1000 Value-Defensive Index	06-30	CI
Edwards Lifesciences Corporation(NYSE:EW) added to Russell 1000 Value Index	06-30	CI
Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	06-20	MT
Edwards Lifesciences Corporation Announces Executive Changes	06-17	CI
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75	06-17	MT
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	06-05	CI
Transcript : Edwards Lifesciences Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:30 AM	06-05
Transcript : Edwards Lifesciences Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 12:00 PM	06-04
Sector Update: Health Care Stocks Steady Premarket Monday	06-03	MT
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	06-03	MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	06-03	RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	06-03	MT
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.	06-02	CI
Some of the biggest splits in Corporate America	05-23	RE
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	05-22	MT
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	05-14	MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	05-13	MT
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	05-13	MT
Edwards Lifesciences hit with Meril's EU antitrust complaint	05-13	RE
Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	05-09	CI
Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100	05-07	MT

Chart Edwards Lifesciences Corporation

Duration

Period

More charts

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

Advanced Medical Equipment & Technology

Calendar

24/07/2024 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 04:25 pm

More Strategies

Ratings for Edwards Lifesciences Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

92.32 USD

Average target price

96.13 USD

Spread / Average Target

+4.12%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
EDWARDS LIFESCIENCES CORPORATION	+21.08%	55.63B
THERMO FISHER SCIENTIFIC	+1.75%	206B
DANAHER CORPORATION	+3.42%	177B
INTUITIVE SURGICAL, INC.	+31.54%	157B
BOSTON SCIENTIFIC CORPORATION	+32.16%	112B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-1.61%	47.57B
AGILENT TECHNOLOGIES, INC.	-9.11%	36.87B
GE HEALTHCARE TECHNOLOGIES INC.	-0.34%	35.18B
RESMED, INC.	+13.21%	28.61B
PHILIPS NV	+20.90%	24.89B

Other Advanced Medical Equipment & Technology